Figure 1From: Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control Incidence (% of patients) of acute and late gastrointestinal (GI) and genitourinary (GU) toxicity. Back to article page